Blue Jet Healthcare Limited (BLUEJET) - Total Assets
Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) holds total assets worth Rs15.27 Billion INR (≈ $165.19 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BLUEJET net assets for net asset value and shareholders' equity analysis.
Blue Jet Healthcare Limited - Total Assets Trend (2020–2025)
This chart illustrates how Blue Jet Healthcare Limited's total assets have evolved over time, based on quarterly financial data.
Blue Jet Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Blue Jet Healthcare Limited's total assets of Rs15.27 Billion consist of 71.0% current assets and 29.0% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 8.5% |
| Accounts Receivable | Rs3.50 Billion | 24.7% |
| Inventory | Rs2.64 Billion | 18.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs5.13 Million | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Blue Jet Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Blue Jet Healthcare Limited market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Blue Jet Healthcare Limited's current assets represent 71.0% of total assets in 2025, an increase from 66.3% in 2020.
- Cash Position: Cash and equivalents constituted 8.5% of total assets in 2025, up from 2.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 24.7% of total assets.
Blue Jet Healthcare Limited Competitors by Total Assets
Key competitors of Blue Jet Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Argen-X
F:1AE
|
Germany | €7.18 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229
|
China | CN¥3.06 Billion |
|
R&G PharmaStudies Co. Ltd. A
SHE:301333
|
China | CN¥2.31 Billion |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
|
China | CN¥819.45 Million |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
China | CN¥2.16 Billion |
Blue Jet Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.11 | 3.24 | 3.40 |
| Quick Ratio | 3.29 | 2.51 | 2.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs7.49 Billion | Rs5.50 Billion | Rs3.96 Billion |
Blue Jet Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Blue Jet Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.49 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 33.9% |
| Total Assets | Rs14.18 Billion |
| Market Capitalization | $833.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values Blue Jet Healthcare Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Blue Jet Healthcare Limited's assets grew by 33.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Blue Jet Healthcare Limited (2020–2025)
The table below shows the annual total assets of Blue Jet Healthcare Limited from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs14.18 Billion ≈ $153.30 Million |
+33.87% |
| 2024-03-31 | Rs10.59 Billion ≈ $114.51 Million |
+22.83% |
| 2023-03-31 | Rs8.62 Billion ≈ $93.23 Million |
+20.84% |
| 2022-03-31 | Rs7.13 Billion ≈ $77.15 Million |
+33.02% |
| 2021-03-31 | Rs5.36 Billion ≈ $58.00 Million |
+42.86% |
| 2020-03-31 | Rs3.75 Billion ≈ $40.60 Million |
-- |
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more